Riskpilot← Back to searchSign inGet full accessFerrosan Medical Devices MidCo ApS
APSActiveCVR 43531042Sydmarken 5Activities of holding companies · NACE 6421Est. 2022— employees
Revenue 2025
DKK -341K
+13% vs 2024
EBITDA margin
3300.9%
-578% vs 2024
Equity ratio
99.2%
Financial strength
Net profit 2025
DKK -10,6M
-392% vs 2024
| Revenue | DKK -341K | +13% |
| EBITDA | DKK -11,3M | -578% |
| Net profit | DKK -10,6M | -392% |
| Total assets | DKK 2,9B | +0% |
| Equity | DKK 2,9B | +0% |
| Employees | — | — |
Legal name
Ferrosan Medical Devices MidCo ApS
CVR number
43531042
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
22. september 2022
Share capital
DKK 10.000.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse, eller af to bestyrelsesmedlemmer i forening eller af en direktør i forening med bestyrelsens formand.
Company purpose
Selskabets formål er at (i) besidde aktier og finansielle instrumenter og (ii) at drive anden virksomhed, der efter direktionens skøn er direkte eller indirekte forbundet hermed.
Address
Sydmarken 5
Phone
+4570252860
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | -63 | -249 | -301 | -341 |
| Staff expenses | -0 | -14.124 | -2.655 | -10.915 |
| EBITDA | -63 | -14.373 | 2.354 | -11.256 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | -63 | -14.373 | 2.354 | -11.256 |
| Net financials | 0 | 1.859 | 1.543 | 1.087 |
| Profit before tax | -63 | -12.514 | 3.897 | -10.169 |
| Tax | -14 | 238 | 273 | 416 |
| Net profit | -49 | -12.752 | 3.624 | -10.585 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2.906.915 | 2.908.754 | 2.912.669 | 2.909.794 |
| Equity | 2.906.852 | 2.894.100 | 2.897.724 | 2.887.139 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 63 | 530 | 14.945 | 22.655 |
| Total debt | 63 | 530 | 14.945 | 22.655 |
EBITDA margin
-1125600000.0%
This company
15.8%
Market median
-7124050733% vs market
20222025
Equity ratio
99.2%
This company
38.2%
Market median
+160% vs market
20222025
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
20222025
Net profit margin
-1058500000.0%
This company
8.1%
Market median
-13067901335% vs market
20222025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20222025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-09-22 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HH Management | Management | 2023 | — | — |
AB Management | Management | 2022 | — | — |
RH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ferrosan Medical Devices HoldCo ApS | Company | 90.0% | 90.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LUNDBECKFONDENLUNDBECKFOND INVEST A/SFerrosan Medical Devices HoldCo ApS
Ferrosan Medical Devices MidCo ApS (this company)Board members of Ferrosan Medical Devices MidCo ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Henrik Pauk Pedersen | Management | 0 companies |
| Anja Bach Eriksson | Management | 0 companies |
| Rasmus Hother le Fevre | Chief Executive Officer | 0 companies |
| Peter Henrik Kürstein-Jensen | Chairman | 0 companies |
| Mia Bielecki | Board of Directors | 0 companies |
| Staffan Percy Ternström | Board of Directors | 0 companies |
| Kim Gulstad | Deputy Chairman | 0 companies |
| Allan Bjørn Rasmussen | Board of Directors | 0 companies |
| Anders Christian Schelde | Board of Directors | 0 companies |
| Arne Due-Hansen | Board of Directors | 0 companies |